Integration of Genomics, Metabolomics, and Host Immunity: A focus of Metabolic Immune System
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 10867
Special Issue Editors
Interests: metabolomics; metabolomics profiling; gut microbiome; immunology
Special Issues, Collections and Topics in MDPI journals
Interests: human disease; genetics and molecular biology; toxicology; molecular biology; immunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The scope of this Special Issue covers the recent progress in immunological metabolites as they are related to immunology, host immunity, and vaccines. Our key aim is to bring the latest advances in various metabolic approaches for the detection and treatment of various types of diseases. Metabolomics and metabolite profiling research in the field of COVID-19 will be a strong focus in this Special Issue. Further metabolite, immunity, and metabolic pathway development research is more important for the treatment of COVID-19. Additionally, this Issue aims to cover the gene, mRNA, protein, and metabolite-based immunological pathway analysis and the pharmaceutical development and impact on disease prevention.
Dr. Raja Ganesan
Dr. Abilash Valsala Gopalakrishnan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolomics
- immunology
- immunity
- microbiota
- metabolites
- COVID-19
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.